Amgen has acquired Dark Blue Therapeutics, a UK-based biotech firm, in a deal worth $840 million. This purchase aims to accelerate Amgen’s advancements in developing innovative cancer therapies.
Back
Silicon Republic
Next Post
Aligning Company Culture with Profit: Why It Matters and How to Achieve It
Related Posts
Customer Expectations Held Flat for Eleven Years. Patience Ran Out.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
How Enterprise Marketing Teams Are Using Neuromarketing Research to Win in Regulated Categories
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More